Chromosome 17 polysomy: correlation with histological parameters andHER2NEUgene amplification
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chromosome 17 polysomy: correlation with histological parameters andHER2NEUgene amplification
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PATHOLOGY
Volume 66, Issue 12, Pages 1070-1075
Publisher
BMJ
Online
2013-08-02
DOI
10.1136/jclinpath-2013-201506
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic alterations and protein expression of HER2 and chromosome 17 polysomy in breast cancer
- (2011) Xiaoli Zhu et al. HUMAN PATHOLOGY
- Impact of chromosome 17 centromere region assessment on HER2 status reported in breast cancer
- (2011) Kristof Egervari et al. PATHOLOGY RESEARCH AND PRACTICE
- Her-2/neu Overexpression Due to Polysomy 17 in Breast Cancer: Molecular Testing to Guide Therapeutic Options
- (2011) Rashmita Sahoo et al. Oncology Research and Treatment
- Assessment of HER2 gene status in breast carcinomas with polysomy of chromosome 17
- (2010) Semir Vranic et al. CANCER
- Chromosome 17 Polysomy without Human Epidermal Growth Factor Receptor 2 Amplification Does Not Predict Response to Lapatinib Plus Paclitaxel Compared with Paclitaxel in Metastatic Breast Cancer
- (2010) L. Downey et al. CLINICAL CANCER RESEARCH
- Chromosome 17 Polysomy without HER2 Amplification Does Not Predict Response to Lapatinib in Metastatic Breast Cancer--Letter
- (2010) C. B. Moelans et al. CLINICAL CANCER RESEARCH
- Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)
- (2010) John MS Bartlett et al. LANCET ONCOLOGY
- Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplification
- (2009) Cathy B. Moelans et al. BREAST CANCER RESEARCH AND TREATMENT
- Effect of High Copy Number of HER2 Associated With Polysomy 17 on HER2 Protein Expression in Invasive Breast Carcinoma
- (2009) Sejal S. Shah et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescencein situhybridization and microarray-based CGH analysis
- (2009) Caterina Marchiò et al. JOURNAL OF PATHOLOGY
- Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response
- (2009) Monica M Reinholz et al. LANCET ONCOLOGY
- Poor prognostic significance of unamplified chromosome 17 polysomy in invasive breast carcinoma
- (2009) Uma Krishnamurti et al. MODERN PATHOLOGY
- Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event
- (2009) I-Tien Yeh et al. MODERN PATHOLOGY
- The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
- (2009) J. S. Ross et al. ONCOLOGIST
- Polysomy 17 in Breast Cancer: Clinicopathologic Significance and Impact on HER-2 Testing
- (2008) Isabelle Vanden Bempt et al. JOURNAL OF CLINICAL ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started